Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data

Over the last 20 years, the greatly improved knowledges of underlying pathogenic mechanisms of AS, including the role of tumor necrosis factor (TNF), the interleukin 23/Th17 axis, and interleukin-17 (Il-17), constituted the rationale to develop biologics selectively inhibiting these pathways. For mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Benucci, Maurizio, Damiani, Arianna, Li Gobbi, Francesca, Grossi, Valentina, Infantino, Maria, Manfredi, Mariangela, Niccoli, Laura, Cantini, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170548/
https://www.ncbi.nlm.nih.gov/pubmed/32368068
http://dx.doi.org/10.2147/TCRM.S228880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170548/
https://www.ncbi.nlm.nih.gov/pubmed/32368068
http://dx.doi.org/10.2147/TCRM.S228880

Ejemplares similares